
At Daiichi Sankyo, we are united by a single purpose, to improve lives around the world through innovative medicines. With a legacy of innovation since 1899, a presence in more than 30 countries, and more than 19,000 employees, we are advancing breakthrough therapies in oncology, cardiovascular disease, rare diseases, and immune disorders. Guided by our 2030 vision to "be an innovative global healthcare company contributing to the sustainable development of society", we are shaping a healthier, more hopeful future for patients, their families, and society.
We are currently seeking a Regulatory Operations/Global Regulatory Affairs Intern from June 2027 – May 2028. This position works for approximately 37.5 hours per week in the summer and 20 hours per week for the remainder of the internship.
The Regulatory Automation & AI Developer Intern will support the Global Regulatory Operations team in designing, developing, and implementing innovative automation and artificial intelligence solutions that improve operational efficiency, quality, and regulatory submission processes. This role provides an excellent opportunity to gain hands-on experience applying AI, machine learning, data science, and software development skills in a highly regulated pharmaceutical environment.
The intern will work closely with regulatory operations, business process owners, and technology teams to identify opportunities for automation, develop proof-of-concept solutions, and help deploy scalable tools that enhance productivity and decision-making.
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
USD$17.23 – USD$58.15

Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need.
For all other inquiries about Daiichi Sankyo such as products or careers, please visit our website www.daiichisankyo.com.